Cite
MLA Citation
Mustafa Khasraw et al.. “ACTR-24. A RANDOMIZED PHASE II TRIAL OF VELIPARIB (V), RADIOTHERAPY (RT) AND TEMOZOLOMIDE (TMZ) IN PATIENTS (PTS) WITH UNMETHYLATED MGMT (uMGMT) GLIOBLASTOMA (GBM): THE VERTU STUDY.” Neuro-oncology, vol. 21, n.d., p. vi18. http://access.bl.uk/ark:/81055/vdc_100101668836.0x00004b